Syrma SGS Technology Ltd (SYRMA) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Syrma SGS Technology reported a strong quarter, achieving a 24% year-on-year revenue growth, reaching 892 crores. Nine-month revenue reached 2,900 crores, a 40% increase.
- Management's efforts to improve margins yielded positive results, with a 9.1% operating EBITDA margin for the quarter and 7.2% for the nine months, exceeding the 7% guidance.
- PBT saw substantial growth, 144% for the quarter and 37% for the nine months.
- Exports remained subdued at 20% due to the economic slowdown in Europe, particularly Germany. However, positive indications suggest a rebound in the coming year.
- MedTech business experienced slow growth due to customer push-outs and product development delays, but a recovery is expected in the next quarter.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.